fridmanwh

Presence of tertiary lymphoid structures as a predictive biomarker of immune-checkpoint inhibitors benefit in sarcomas: moving toward personalized immunotherapy for our patients

Online @nature: Three studies describe the role of B cells in #cancer immunology and #immunotherapy. Great collaboration by @Helmbeth @JenWargoMD @jonsson_lab @fridmanwh @sautesfridm @petiprez_f @ritacabrita8 nature.com/articles/s4158… nature.com/articles/s4158… nature.com/articles/s4158…